408 related articles for article (PubMed ID: 30734066)
1. The efficacy and safety of menatetrenone in the management of osteoporosis: a systematic review and meta-analysis of randomized controlled trials.
Su S; He N; Men P; Song C; Zhai S
Osteoporos Int; 2019 Jun; 30(6):1175-1186. PubMed ID: 30734066
[TBL] [Abstract][Full Text] [Related]
2. Pharmacological interventions versus placebo, no treatment or usual care for osteoporosis in people with chronic kidney disease stages 3-5D.
Hara T; Hijikata Y; Matsubara Y; Watanabe N
Cochrane Database Syst Rev; 2021 Jul; 7(7):CD013424. PubMed ID: 34231877
[TBL] [Abstract][Full Text] [Related]
3. Menatetrenone versus alfacalcidol in the treatment of Chinese postmenopausal women with osteoporosis: a multicenter, randomized, double-blinded, double-dummy, positive drug-controlled clinical trial.
Jiang Y; Zhang ZL; Zhang ZL; Zhu HM; Wu YY; Cheng Q; Wu FL; Xing XP; Liu JL; Yu W; Meng XW
Clin Interv Aging; 2014; 9():121-7. PubMed ID: 24426779
[TBL] [Abstract][Full Text] [Related]
4. Menatetrenone for the treatment of osteoporosis.
Iwamoto J; Sato Y
Expert Opin Pharmacother; 2013 Mar; 14(4):449-58. PubMed ID: 23346882
[TBL] [Abstract][Full Text] [Related]
5. Vitamin K₂ therapy for postmenopausal osteoporosis.
Iwamoto J
Nutrients; 2014 May; 6(5):1971-80. PubMed ID: 24841104
[TBL] [Abstract][Full Text] [Related]
6. Vitamin K to prevent fractures in older women: systematic review and economic evaluation.
Stevenson M; Lloyd-Jones M; Papaioannou D
Health Technol Assess; 2009 Sep; 13(45):iii-xi, 1-134. PubMed ID: 19818211
[TBL] [Abstract][Full Text] [Related]
7. Strontium ranelate for preventing and treating postmenopausal osteoporosis.
O'Donnell S; Cranney A; Wells GA; Adachi JD; Reginster JY
Cochrane Database Syst Rev; 2006 Jul; (3):CD005326. PubMed ID: 16856092
[TBL] [Abstract][Full Text] [Related]
8. Does vitamin K2 play a role in the prevention and treatment of osteoporosis for postmenopausal women: a meta-analysis of randomized controlled trials.
Huang ZB; Wan SL; Lu YJ; Ning L; Liu C; Fan SW
Osteoporos Int; 2015 Mar; 26(3):1175-86. PubMed ID: 25516361
[TBL] [Abstract][Full Text] [Related]
9. Efficacy and safety of bazedoxifene in postmenopausal women with osteoporosis: A systematic review and meta-analysis.
Peng L; Luo Q; Lu H
Medicine (Baltimore); 2017 Dec; 96(49):e8659. PubMed ID: 29245225
[TBL] [Abstract][Full Text] [Related]
10. Short-term menatetrenone therapy increases gamma-carboxylation of osteocalcin with a moderate increase of bone turnover in postmenopausal osteoporosis: a randomized prospective study.
Shiraki M; Itabashi A
J Bone Miner Metab; 2009; 27(3):333-40. PubMed ID: 19172219
[TBL] [Abstract][Full Text] [Related]
11. Drug efficacies on bone mineral density and fracture rate for the treatment of postmenopausal osteoporosis: a network meta-analysis.
Yang L; Kang N; Yang JC; Su QJ; Liu YZ; Guan L; Liu T; Meng XL; Wang Y; Hai Y
Eur Rev Med Pharmacol Sci; 2019 Mar; 23(6):2640-2668. PubMed ID: 30964193
[TBL] [Abstract][Full Text] [Related]
12. Efficacy and safety of 18 anti-osteoporotic drugs in the treatment of patients with osteoporosis caused by glucocorticoid: A network meta-analysis of randomized controlled trials.
Liu Z; Zhang M; Shen Z; Ke J; Zhang D; Yin F
PLoS One; 2020; 15(12):e0243851. PubMed ID: 33326444
[TBL] [Abstract][Full Text] [Related]
13. Efficacy of bisphosphonates against osteoporosis in adult men: a meta-analysis of randomized controlled trials.
Chen L; Wang G; Zheng F; Zhao H; Li H
Osteoporos Int; 2015 Sep; 26(9):2355-63. PubMed ID: 25944731
[TBL] [Abstract][Full Text] [Related]
14. Efficacy of statins for osteoporosis: a systematic review and meta-analysis.
An T; Hao J; Sun S; Li R; Yang M; Cheng G; Zou M
Osteoporos Int; 2017 Jan; 28(1):47-57. PubMed ID: 27888285
[TBL] [Abstract][Full Text] [Related]
15. Combination therapy with parathyroid hormone analogs and antiresorptive agents for osteoporosis: a systematic review and meta-analysis of randomized controlled trials.
Lou S; Lv H; Yin P; Li Z; Tang P; Wang Y
Osteoporos Int; 2019 Jan; 30(1):59-70. PubMed ID: 30539271
[TBL] [Abstract][Full Text] [Related]
16. Bisphosphonates for osteoporosis in primary biliary cirrhosis.
Rudic JS; Giljaca V; Krstic MN; Bjelakovic G; Gluud C
Cochrane Database Syst Rev; 2011 Dec; (12):CD009144. PubMed ID: 22161446
[TBL] [Abstract][Full Text] [Related]
17. Efficacy of vitamin K2 in the prevention and treatment of postmenopausal osteoporosis: A systematic review and meta-analysis of randomized controlled trials.
Ma ML; Ma ZJ; He YL; Sun H; Yang B; Ruan BJ; Zhan WD; Li SX; Dong H; Wang YX
Front Public Health; 2022; 10():979649. PubMed ID: 36033779
[TBL] [Abstract][Full Text] [Related]
18. Comparative efficacy of bone anabolic therapies in women with postmenopausal osteoporosis: A systematic review and network meta-analysis of randomized controlled trials.
Hernandez AV; Pérez-López FR; Piscoya A; Pasupuleti V; Roman YM; Thota P; Herrera A
Maturitas; 2019 Nov; 129():12-22. PubMed ID: 31547908
[TBL] [Abstract][Full Text] [Related]
19. Teriparatide versus bisphosphonates for treatment of postmenopausal osteoporosis: A meta-analysis.
Yuan F; Peng W; Yang C; Zheng J
Int J Surg; 2019 Jun; 66():1-11. PubMed ID: 30890377
[TBL] [Abstract][Full Text] [Related]
20. Safety of denosumab in postmenopausal women with osteoporosis or low bone mineral density: a meta-analysis.
Zhou Z; Chen C; Zhang J; Ji X; Liu L; Zhang G; Cao X; Wang P
Int J Clin Exp Pathol; 2014; 7(5):2113-22. PubMed ID: 24966919
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
